Skip to Main Content

Author Details

Tanja Pejovic
Oregon Health & Science University
1989
162
37
PMIDPaper TitleJournal TitlePublished Year
36410423Adnexal masses during pregnancy: diagnosis, treatment, and prognosis.Am J Obstet Gynecol2023
37518857Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers.Small2023
37460033Trends in permanent contraceptive procedural volume in the United States between 2019 and 2020.Am J Obstet Gynecol2023
37126016Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial.Clin Cancer Res2023
37369443Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.Can J Surg2023
36790339Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma.Cancer Epidemiol Biomarkers Prev2023
36744876Au-Loaded Superparamagnetic Mesoporous Bimetallic CoFeB Nanovehicles for Sensitive Autoantibody Detection.ACS Nano2023
35176661Evidence of cancer therapy-induced chronic inflammation in the ovary across multiple species: A potential cause of persistent tissue damage and follicle depletion.J Reprod Immunol2022
35804849Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian Cancer.Cancers (Basel)2022
35800377Ovarian cancer recurrence: "is the definition of platinum resistance modified by PARP inhibitors and other intervening treatments?"Cancer Drug Resist2022
35692807Single-Cell Proteomics Analysis of Recurrent Low-Grade Serous Ovarian Carcinoma and Associated Brain Metastases.Front Oncol2022
35454861CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter Analysis.Cancers (Basel)2022
36210504Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.J Natl Cancer Inst2022
36098251Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated Cachexia.Small2022
34162658Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2021
33681988Matrix-free 3D culture supports human follicular development from the unilaminar to the antral stage in vitro yielding morphologically normal metaphase II oocytes.Hum Reprod2021
33923934Intersection of DNA Repair Pathways and the Immune Landscape Identifies PD-L2 as a Prognostic Marker in Epithelial Ovarian Cancer.Cancers (Basel)2021
34298602Extracellular Vesicle Transmission of Chemoresistance to Ovarian Cancer Cells Is Associated with Hypoxia-Induced Expression of Glycolytic Pathway Proteins, and Prediction of Epithelial Ovarian Cancer Disease Recurrence.Cancers (Basel)2021
32165999Subcellular localization of FANCD2 is associated with survival in ovarian carcinoma.Oncotarget2020
33227068Association between vitamin D and ovarian cancer development in <i>BRCA1</i> mutation carriers.Oncotarget2020
32885016Broad ligament Extraintestinal Gastrointestinal Stromal Tumor (EGIST): Case report and brief overview of EGIST.Gynecol Oncol Rep2020
32595827The prognostic significance of GRB7 protein expression and localization in human breast and ovarian cancers.Oncotarget2020
32555365Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.Br J Cancer2020
32334098miRNa signature in small extracellular vesicles and their association with platinum resistance and cancer recurrence in ovarian cancer.Nanomedicine2020
32406029Endometriosis and Endometriosis-Associated Ovarian Cancer (EAOC).Adv Exp Med Biol2020
30683880Shared heritability and functional enrichment across six solid cancers.Nat Commun2019
31825847A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor Development.Cell Rep2019
31548585Publisher Correction: Shared heritability and functional enrichment across six solid cancers.Nat Commun2019
31196490Tumor characteristics and outcome of uterine carcinosarcoma in women aged â¿¥80 years.Surg Oncol2019
31194214Immune Checkpoint and Poly(ADP-Ribose) Polymerase Inhibition for Recurrent Platinum-Resistant Ovarian and Metastatic Triple-Negative Breast Cancers.JAMA Oncol2019
31043753A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants.Nat Genet2019
30886884The dilemma of early preventive oophorectomy in familial small cell carcinoma of the ovary of hypercalcemic type.Gynecol Oncol Rep2019
31001917Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.Cancer Med2019
28787528Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma.J Surg Oncol2018
30134598rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.Int J Mol Sci2018
30105438Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma.Ann Surg Oncol2018
30054336A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk.Cancer Res2018
30217299Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element.Surg Oncol2018
29971677Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma.Ann Surg Oncol2018
30207096Clinical utility of CA-125 in the management of uterine carcinosarcoma.J Gynecol Oncol2018
29979793Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility.PLoS One2018
30456287Primary mediastinal choriocarcinoma in a female patient: Case report and review of the literature.Gynecol Oncol Rep2018
29555990Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.Br J Cancer2018
29381474Professionally responsible management of gynecologic cancer in pregnancy when clinical resources are unavoidably limited.J Perinat Med2018
29717883Drugging homologous recombination: back to the future.Future Med Chem2018
29248197Significance of venous thromboembolism in women with uterine carcinosarcoma.Gynecol Oncol2018
29044542Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery.J Surg Oncol2018
28050675Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium.Cancer Causes Control2017
28456378High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer.Gynecol Oncol2017
28331900A recurrent endometrial stromal sarcoma harbors the novel fusion <i>JAZF1-BCORL1</i>.Gynecol Oncol Rep2017
  • 1 - 50 of 162

Recommended Authors

Amy Lum
University of British Columbia
Career Start Year 2014
Number of shared co-authors 97
Myriam Kossai
INSERM, Universite Clermont Auvergne
Career Start Year 2008
Number of shared co-authors 1
Yingmei Wang
Tianjin Medical University General Hospital
Career Start Year 2007
Number of shared co-authors 1
Shin-Wha Lee
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 1
Divya Gupta
Emory University School of Medicine
Career Start Year 2006
Number of shared co-authors 2
Dariush Etemadmoghadam
Peter MacCallum Cancer Centre
Career Start Year 2004
Number of shared co-authors 31
Leah M Prentice
British Columbia Women's Hospital and Health Centre
Career Start Year 2004
Number of shared co-authors 36
Robyn A Sayer
Westmead Hospital
Career Start Year 2003
Number of shared co-authors 89
Sven Mahner
University Hospital
Career Start Year 2002
Number of shared co-authors 95
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 30
Blaise A Clarke
University of Toronto.
Career Start Year 2001
Number of shared co-authors 51
Saravut J Weroha
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 21
Aparna A Kamat
Houston Methodist Hospital
Career Start Year 2000
Number of shared co-authors 3
Steve E Kalloger
University of British Columbia
Career Start Year 2000
Number of shared co-authors 30
Susan C Modesitt
University of Virginia, Emily Couric Clinical Cancer Center
Career Start Year 1998
Number of shared co-authors 7
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 1
Yong-Man Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1994
Number of shared co-authors 1
Janine Senz
University of British Columbia
Career Start Year 1994
Number of shared co-authors 116
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 3
Holger Moch
University Hospital Zurich
Career Start Year 1991
Number of shared co-authors 7
Rosemarie Schmandt
The University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 7
Patricia A Shaw
Princess Margaret Cancer Centre, University Avenue
Career Start Year 1990
Number of shared co-authors 45
Fr??d??ric Amant
Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 68
Lora H Ellenson
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 6
Juan P Palazzo
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 6
Cyril B Gilks
University of British Columbia
Career Start Year 1987
Number of shared co-authors 116
Rex C Bentley
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 97
Jos?? Palacios
Universidad de Alcala
Career Start Year 1983
Number of shared co-authors 103
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 8
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 6

Collaborators

Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 50
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 50
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 47
Andrew Berchuck
Duke School of Medicine
Co-authored papers 47
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 46
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 45
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 43
Diether Lambrechts
Co-authored papers 43
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 43
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 42
Honglin Song
University of Cambridge
Co-authored papers 40
Anna H Wu
University of Southern California
Co-authored papers 40
Jacek Gronwald
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 40
Weiva Sieh
Co-authored papers 40
Hoda Anton-Culver
University of California irvine
Co-authored papers 40
Mary Anne Rossing
Fred Hutchinson Cancer Research Center
Co-authored papers 39
Elisa V Bandera
Co-authored papers 39
Douglas A Levine
Perlmutter Cancer Center
Co-authored papers 39
Nicolas Wentzensen
National Cancer Institute, National Institutes of Health
Co-authored papers 38
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 38
Ian G Campbell
Co-authored papers 38
Usha Menon
College of Nursing, University of South Florida
Co-authored papers 38
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 38
Jennifer A Doherty
Huntsman Cancer Institute, University of Utah
Co-authored papers 37
Celeste Leigh Pearce
University of Michigan School of Public Health ann arbor
Co-authored papers 37
Jenny Lester
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 37
Alice S Whittemore
Co-authored papers 36
Jan Lubinski
Pomeranian Medical University
Co-authored papers 36
Aleksandra Gentry-Maharaj
UCL EGA Institute for Women's Health, University College London
Co-authored papers 36
Jonathan Tyrer
Co-authored papers 36
Release 1.2